These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 15948135)
1. Patupilone (epothilone B, EPO906) inhibits growth and metastasis of experimental prostate tumors in vivo. O'Reilly T; McSheehy PM; Wenger F; Hattenberger M; Muller M; Vaxelaire J; Altmann KH; Wartmann M Prostate; 2005 Nov; 65(3):231-40. PubMed ID: 15948135 [TBL] [Abstract][Full Text] [Related]
2. Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo. Hofstetter B; Vuong V; Broggini-Tenzer A; Bodis S; Ciernik IF; Fabbro D; Wartmann M; Folkers G; Pruschy M Clin Cancer Res; 2005 Feb; 11(4):1588-96. PubMed ID: 15746064 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo. O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895 [TBL] [Abstract][Full Text] [Related]
4. Different effect of paclitaxel on primary tumor mass, tumor cell contents, and metastases for four experimental human prostate tumors expressing luciferase. El Hilali N; Rubio N; Blanco J Clin Cancer Res; 2005 Feb; 11(3):1253-8. PubMed ID: 15709196 [TBL] [Abstract][Full Text] [Related]
5. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342 [TBL] [Abstract][Full Text] [Related]
6. Role of the microenvironment for radiosensitization by patupilone. Bley CR; Jochum W; Orlowski K; Furmanova P; Vuong V; McSheehy PM; Pruschy M Clin Cancer Res; 2009 Feb; 15(4):1335-42. PubMed ID: 19228735 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic cure against human tumor xenografts in nude mice by a microtubule stabilization agent, fludelone, via parenteral or oral route. Chou TC; Dong H; Zhang X; Tong WP; Danishefsky SJ Cancer Res; 2005 Oct; 65(20):9445-54. PubMed ID: 16230408 [TBL] [Abstract][Full Text] [Related]
8. Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure. Ferretti S; Allegrini PR; O'Reilly T; Schnell C; Stumm M; Wartmann M; Wood J; McSheehy PM Clin Cancer Res; 2005 Nov; 11(21):7773-84. PubMed ID: 16278399 [TBL] [Abstract][Full Text] [Related]
9. Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts. Low JC; Wasan KM; Fazli L; Eberding A; Adomat H; Guns ES Cancer Chemother Pharmacol; 2007 Nov; 60(6):821-9. PubMed ID: 17294190 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor. Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333 [TBL] [Abstract][Full Text] [Related]
11. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Xiao D; Lew KL; Kim YA; Zeng Y; Hahm ER; Dhir R; Singh SV Clin Cancer Res; 2006 Nov; 12(22):6836-43. PubMed ID: 17121905 [TBL] [Abstract][Full Text] [Related]
12. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers. Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707 [TBL] [Abstract][Full Text] [Related]
13. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice. Zheng X; Chang RL; Cui XX; Avila GE; Hebbar V; Garzotto M; Shih WJ; Lin Y; Lu SE; Rabson AB; Kong AN; Conney AH Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3444-51. PubMed ID: 16740769 [TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice. Yazici S; Kim SJ; Busby JE; He J; Thaker P; Yokoi K; Fan D; Fidler IJ Prostate; 2005 Nov; 65(3):203-15. PubMed ID: 15948138 [TBL] [Abstract][Full Text] [Related]
15. Noscapine inhibits human prostate cancer progression and metastasis in a mouse model. Barken I; Geller J; Rogosnitzky M Anticancer Res; 2008; 28(6A):3701-4. PubMed ID: 19189652 [TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models. Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787 [TBL] [Abstract][Full Text] [Related]
17. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
18. Preclinical antitumor activity of the oral platinum analog satraplatin. Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592 [TBL] [Abstract][Full Text] [Related]
19. Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI). Chang XH; Fu YW; Na WL; Wang J; Sun H; Cai L Anticancer Res; 1999; 19(5B):4199-202. PubMed ID: 10628375 [TBL] [Abstract][Full Text] [Related]
20. Effect of sildenafil citrate on an orthotopic prostate cancer growth and metastasis model. Qian CN; Takahashi M; Kahnoski R; Teh BT J Urol; 2003 Sep; 170(3):994-7. PubMed ID: 12913757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]